These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 6853708)

  • 1. Platelet-derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro.
    Dainiak N; Davies G; Kalmanti M; Lawler J; Kulkarni V
    J Clin Invest; 1983 May; 71(5):1206-14. PubMed ID: 6853708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor enhances in vitro erythropoiesis via stimulation of mesenchymal cells.
    Delwiche F; Raines E; Powell J; Ross R; Adamson J
    J Clin Invest; 1985 Jul; 76(1):137-42. PubMed ID: 4019772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells.
    Mangan KF; D'Alessandro L; Mullaney MT
    J Lab Clin Med; 1986 Apr; 107(4):353-64. PubMed ID: 2420910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylated lipoproteins impair erythroid growth factor release from endothelial cells.
    Dainiak N; Warren HB; Kreczko S; Riordan MA; Feldman L; Lawler J; Cohen AM; Davies PF
    J Clin Invest; 1988 Mar; 81(3):834-43. PubMed ID: 3278006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.
    Feldman L; Frazier JG; Sytkowski AJ
    Exp Hematol; 1992 Nov; 20(10):1223-8. PubMed ID: 1426102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of insulin, insulinlike growth factor II, and platelet-derived growth factor in erythropoietic culture.
    Dainiak N; Kreczko S
    J Clin Invest; 1985 Sep; 76(3):1237-42. PubMed ID: 3900135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-triiodothyronine augments erythropoietic growth factor release from peripheral blood and bone marrow leukocytes.
    Dainiak N; Sutter D; Kreczko S
    Blood; 1986 Dec; 68(6):1289-97. PubMed ID: 3490885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.
    Sieff CA; Emerson SG; Mufson A; Gesner TG; Nathan DG
    J Clin Invest; 1986 Jan; 77(1):74-81. PubMed ID: 3511093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development.
    Sawada K; Krantz SB; Dessypris EN; Koury ST; Sawyer ST
    J Clin Invest; 1989 May; 83(5):1701-9. PubMed ID: 2651478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human bone marrow stromal cell colonies: response to hydrocortisone and dependence on platelet-derived growth factor.
    McIntyre AP; Bjornson BH
    Exp Hematol; 1986 Oct; 14(9):833-9. PubMed ID: 3019748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of platelet-derived growth factor on human pluripotent progenitor (CFU-GEMM) growth in vitro.
    Michalevicz R; Francis GE; Price GM; Hoffbrand AV
    Leuk Res; 1985; 9(3):399-405. PubMed ID: 3858610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the human erythroid progenitor cells responsive to the erythropoietic-enhancing activity found in normal human serum.
    Mouchiroud G; Blanchet JP
    Int J Cell Cloning; 1987 Nov; 5(6):492-503. PubMed ID: 3429934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary human marrow cultures for erythroid bursts in a serum-substituted system.
    Dainiak N; Kreczko S; Cohen A; Pannell R; Lawler J
    Exp Hematol; 1985 Nov; 13(10):1073-9. PubMed ID: 4054248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the growth of human early erythroid progenitors by bone marrow conditioned media.
    Porter PN; Ogawa M; Leary AG
    Exp Hematol; 1980 Jan; 8(1):83-8. PubMed ID: 7409039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
    Shih LY; Huang JY
    Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
    Malgor LA; Valsecia M; Vergés E; De Markowsky EE
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colony formation in agar by adult bone marrow multipotential hemopoietic cells.
    Johnson GR
    J Cell Physiol; 1980 Jun; 103(3):371-83. PubMed ID: 7400223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cells.
    Currie GA
    Br J Cancer; 1981 Mar; 43(3):335-43. PubMed ID: 7225284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of circulating neonatal stem cell populations.
    Dainiak N; Sanders M; Sorba S
    Blood Cells; 1991; 17(2):339-43. PubMed ID: 1912598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete replacement of serum in cultures of murine primitive erythroid and multipotential progenitor cells: absolute requirement for spleen conditioned medium.
    Cormier F; Baines P; Lucien N; Boffa GA
    Cell Differ; 1985 Nov; 17(4):261-9. PubMed ID: 3841029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.